We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
287 hedge funds and large institutions have $2.36B invested in Corcept Therapeutics in 2024 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 109 increasing their positions, 90 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 40
21% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 90
7.13% more ownership
Funds ownership: 83.49% → 90.62% (+7.1%)
5% more funds holding
Funds holding: 273 → 287 (+14)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
15% less capital invested
Capital invested by funds: $2.79B → $2.36B (-$432M)
21% less call options, than puts
Call options by funds: $65.5M | Put options by funds: $83M
Holders
287
Holders Change
+14
Holders Change %
+5.13%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
56
Increased
109
Reduced
90
Closed
40
Calls
$65.5M
Puts
$83M
Net Calls
-$17.5M
Net Calls Change
-$26.5M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$40M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$17.3M |
| 3 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$16.2M |
| 4 |
Man Group
London,
United Kingdom
|
+$15.9M |
| 5 |
Cerity Partners
New York
|
+$14.2M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$38.7M |
| 2 |
Morgan Stanley
New York
|
-$25.5M |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$15.2M |
| 4 |
D.E. Shaw & Co
New York
|
-$12.4M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$10.9M |
